CALCIUM INFLUX IS SHAPED BY THE MUTATIONAL STATUS IN CIRCULATING CD34+CELLS OF PATIENTS WITH MYELOFIBROSIS

被引：0
|
作者：
Rosti, V. [1 ]
Poletto, V. [1 ]
Canobbio, I. [2 ]
Villani, L. [1 ]
Bonetti, E. [1 ]
Massa, M. [3 ]
Campanelli, R. [1 ]
Fois, G. [1 ]
Torti, M. [2 ]
Tanzi, F. [2 ]
Moccia, F. [2 ]
Barosi, G. [1 ]
机构：
[1] Fdn IRCCS Policlin San Matteo, LSR Area Biotecnol, Ctr Studio & Cura Mielofibrosi, Pavia, Italy
[2] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy
[3] Fdn IRCCS Policlin San Matteo, LSR Area Biotecnol, Pavia, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S818
引用
收藏
页码：328 / 328
页数：1
相关论文
共 50 条
  • [41] DETERMINING THE NUMBER OF CIRCULATING CD34+CELLS FOR THE DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS IN DAILY PRACTICE
    Orvain, C.
    Paz, D. Luque
    Dobo, I.
    Le Calvez, G.
    Chauveau, A.
    Boyer, F.
    Ianotto, J. C.
    Zandecki, M.
    Ifrah, N.
    Ugo, V.
    Genevieve, F.
    HAEMATOLOGICA, 2014, 99 : 661 - 661
  • [42] Reduced CD26 dipeptidylpeptidase IV membrane expression and activity of CD34+cells from patients with myelofibrosis with myeloid metaplasia.
    Campanelli, Rita
    Massa, Margherita
    Rosti, Vittorio
    Bergamaschi, Gaetano
    Viarengo, Gianluca
    Marchetti, Monia
    Hoffman, Ronald
    Barosi, Giovanni
    BLOOD, 2006, 108 (11) : 1033A - 1033A
  • [43] Treatment with Natalizumab in patients with multiple sclerosis is associated with increased numbers of circulating CD34+cells in the peripheral blood
    Zohren, Fabian
    Czibere, Akos
    Toutzaris, Diamandis
    Hartung, Hans-Peter
    Bruns, Ingmar
    Haas, Rainer
    BLOOD, 2007, 110 (11) : 304B - 304B
  • [44] Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+cells of hypertensive patients
    Pirro, Matteo
    Schillaci, Giuseppe
    Menecali, Cinzia
    Bagaglia, Francesco
    Paltriccia, Rita
    Vaudo, Gaetano
    Mannarino, Massimo R.
    Mannarino, Elmo
    JOURNAL OF HYPERTENSION, 2007, 25 (10) : 2093 - 2099
  • [45] Cell cycle status of CD34+cells in human fetal bone marrow
    Koenig, JM
    Luttge, B
    Benson, NA
    Christensen, RD
    EARLY HUMAN DEVELOPMENT, 2001, 65 (02) : 159 - 163
  • [46] Comprehensive genetic characterization of circulating CD34+cells of MDS patients by FISH- and SNP array analysis
    Ganster, C.
    Shirneshan, K.
    Salinas-Riester, G.
    Braulke, F.
    Gotze, K.
    Platzbecker, U.
    Haase, D.
    ONKOLOGIE, 2011, 34 : 207 - 208
  • [47] Effects of ruxolitinib and magrolimab on calreticulin in myelofibrosis CD34+cells in vitro: Proof of concept for combination therapy
    Rinaldi, Ciro Roberto
    Boasman, Kristian
    Simmonds, Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Detection of aberrant signaling pathways in CD34+cells from patients with myelofibrosis with myeloid metaplasia using oligonulceotide microarrays.
    Jones, LC
    Tefferi, A
    Wachsman, W
    Hofmann, WK
    Koeffler, HP
    BLOOD, 2001, 98 (11) : 626A - 626A
  • [49] IMPACT OF NUMBER OF CD34+CELLS INFUSED ON OVERALL SURVIVAL IN MYELOFIBROSIS PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Frioni, Filippo
    Giammarco, Sabrina
    Metafuni, Elisabetta
    Limongiello, Maria Assunta
    Piccirillo, Nicola
    Marra, John Donald
    Di Marino, Luca
    Teofili, Luciana
    Bacigalupo, Andrea
    Sica, Simona
    Chiusolo, Patrizia
    BONE MARROW TRANSPLANTATION, 2024, 59 : 529 - 530
  • [50] Trend of circulating CD34+ cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment
    Iurlo, Alessandra
    Galli, Nicole
    Bucelli, Cristina
    Artuso, Silvia
    Consonni, Dario
    Cattaneo, Daniele
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (03) : 315 - 322
12345